CVS Group Past Earnings Performance

Past criteria checks 2/6

CVS Group has been growing earnings at an average annual rate of 31.3%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 10% per year. CVS Group's return on equity is 10.1%, and it has net margins of 4%.

Key information

31.3%

Earnings growth rate

31.0%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate10.0%
Return on equity10.1%
Net Margin4.0%
Next Earnings Update27 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How CVS Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:CVSG.F Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24647262020
31 Dec 23642351950
30 Sep 23625391860
30 Jun 23589481670
31 Mar 23593361790
31 Dec 22577291810
30 Sep 22566281780
30 Jun 22554261740
31 Mar 22546261670
31 Dec 21538261590
30 Sep 21524221590
30 Jun 21510191580
31 Mar 21480151520
31 Dec 20449111450
30 Sep 2043891370
30 Jun 2042861280
31 Mar 2043291260
31 Dec 19436131230
30 Sep 19421111270
30 Jun 1940781310
31 Mar 1938671300
31 Dec 1836571290
30 Sep 1834691220
30 Jun 18327111160
31 Mar 18314101100
31 Dec 17300101050
30 Sep 1728611980
30 Jun 1727212910
31 Mar 1725911920
31 Dec 1624710920
30 Sep 162328860
30 Jun 162187800
31 Mar 162027740
31 Dec 151866680
30 Sep 151776650
30 Jun 151677610
31 Mar 151627630
31 Dec 141566650
30 Sep 141496580
30 Jun 141435500
31 Mar 141375400

Quality Earnings: CVSG.F has high quality earnings.

Growing Profit Margin: CVSG.F's current net profit margins (4%) are lower than last year (8.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CVSG.F's earnings have grown significantly by 31.3% per year over the past 5 years.

Accelerating Growth: CVSG.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CVSG.F had negative earnings growth (-45.5%) over the past year, making it difficult to compare to the Healthcare industry average (10.4%).


Return on Equity

High ROE: CVSG.F's Return on Equity (10.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 09:56
End of Day Share Price 2024/12/31 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CVS Group plc is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James BaylissBerenberg
Robert ChantryBerenberg
Conall MacCoilleDavy